Mednow Investor Relations Site
  • Home
  • News
  • Media
  • The Team
  • Stock Info
  • Investor Info
    • Financials
    • Governance Docs
    • Research Reports
    • Investor Presentation
  • Investor Contact
Select Page

Media

Gravitas Securities

5th Annual Growth Conference – 2022 – Mednow – Karim Nassar

2022 CEM AlphaNorth Capital Event

MNOW | 2022 CEM AlphaNorth Capital Event

Proactive Investors Research

Proactive Research analyst Danial Appiah analyses Mednow’s fast-growing numbers

Mednow posts strong rise in second-quarter revenue as its retail pharmacy segment soars
Other Proactive Investor Videos
  • Mednow looks to its strict privacy rules to offer piece of mind for platform
  • Mednow launches Total Health personalized plans as it includes supplements in its holistic offering
  • Mednow ‘offers patients a faster and more efficient alternative to old-fashioned pharmacy lineup’
  • Mednow releases financial numbers from Q1, sees revenue growth of 375%
  • Mednow closes acquisition pf London Pharmacare and Liver Canada Care
  • Mednow looks to become National Brand with provincial rollout
  • Mednow looks to be a sector leader as the world embraces the digital pharmacy
  • Mednow makes C$500K investment in US-based Doko Medical, intends to acquire Infusicare
  • Mednow launches Mednow Virtual Care to provide telemedicine services to doctors and pharmacists

Quick Links

Executive Management

Investor FAQs

Sedar Filings

Investor Contact

Benjamin Ferdinand
ir@mednow.ca
+1 855 686 6300

Investor Email Alerts

Unsubscribe

© Mednow All Rights Reserved 2021

Privacy Policy
Mednow is now trading as MNOW in TSXV